Diabetic Foot Ulcers
About Diabetic Foot Ulcers
By the year 2025, there will be 300 million diabetic patients worldwide.1 KCI provides a comprehensive range of solutions that can help reduce time to closure for diabetic ulcers.
Diabetic patients have a lifetime risk between 15% and 25% of developing a diabetic foot ulcer.1,3
Products described on this website (and associated product information), may not be available for sale in all markets as a result of local regulatory requirements. For information regarding product availability in your market, please contact your local Acelity/KCI representative here.
The Science Behind Our Products
Our solutions are built on deep scientific expertise, supported by a large body of clinical evidence.
Diabetes is the leading cause of non-traumatic lower extremity amputations in the United States. 15% of all diabetic foot wounds will result in amputation.2 On average, an extremity is amputated every 30 seconds due to complications of diabetes and the majority of these amputations occur following the development of a diabetic foot ulcer.4
Ulcers form due to a combination of factors, such as lack of feeling in the foot, poor circulation, foot deformities, irritation (such as friction or pressure) and trauma. Fortunately, as research shows, the development of a foot ulcer is preventable.3
KCI provides a wide range of Negative Pressure Wound Therapy systems for hospital, community or home treatment. Since its launch in 1995, V.A.C.® Therapy has changed the way wounds are treated. Backed by more published clinical evidence than any other Negative Pressure Wound Therapy Systems, V.A.C.® Therapy has become the clinician’s treatment of choice for more than 10 million wounds worldwide.* V.A.C.® Therapy promotes wound healing through the application of negative (vacuum) pressure at the wound site. This helps to draw wound edges together, remove infectious materials and actively promote granulation.
*As of 2016. KCI data on file.
Every wound is different. That is why KCI provides a comprehensive range of advanced wound dressings to help address each wound’s specific needs. Our product portfolio is the result of over 80 years of experience in developing innovative solutions to help you manage wounds towards healing.
A number of our advanced wound dressings such as INADINE™ (PVP-I) Non Adherent Dressing, SILVERCEL™ NON-ADHERENT Hydro-Alginate Antimicrobial Dressing with Silver with EASYLIFT™ Precision Film Technology and PROMOGRAN PRISMA™ Wound Balancing Matrix, offer antimicrobial benefits to help infected wounds, while our other advanced wound dressings such as ADAPTIC TOUCH™ Non-Adhering Silicone Dressing serve as a gentle silicone wound contact layer.
TIELLE™ Hydropolymer Dressings with LIQUALOCK™ Advanced Absorption Technology offer moist wound healing which can be conducive to wound healing.
Education is key to promoting quality of care, particularly when it involves the healthcare community. Our instructional programs – from professional training to continuing education – provide a continuum designed to improve skills and enrich knowledge across all healthcare settings.